Viewing StudyNCT00261352



Ignite Creation Date: 2024-05-05 @ 4:34 PM
Last Modification Date: 2024-10-26 @ 9:21 AM
Study NCT ID: NCT00261352
Status: TERMINATED
Last Update Posted: 2009-04-22
First Post: 2005-12-01

Brief Title: GALLANT 14 Tesaglitazar vs Metformin and Fenofibrate
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Type 2 Diabetes
Keywords: